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1. Introduction 
In the era before Therapeutic Hypothermia (TH) was recommended and used as a 
therapeutic modality for out-of-hospital cardiac arrest (OHCA) patients, reported data 
suggests in-hospital mortality exceeded 58%.[1,2,3,4,5,6] Mortality after a sudden and 
unexpected cardiac arrest (CA) is high, and the chance of survival to hospital discharge has, 
until recently, remained unchanged.[7] In one report, OHCA in the U.S. has a mortality rate 
greater than 90% which results in more than 300,000 deaths per year.[8] Those who survive 
the devastating event, often retain a hypoxic brain injury and a permanently incapacitating 
neurologic deficit.[9] Studies of patients who survived to ICU admission but subsequently 
died in the hospital, brain injury was the cause of death in 68% after out-of-hospital cardiac 
arrest and in 23% after in-hospital cardiac arrest.[10,11]  
Recent studies have indicated that TH with a reduction of body core temperature (T) to  
33 °C over 12 to 24 hours has improved survival and neurologic outcome in OHCA patients. 
In 2002, the European Hypothermia after Cardiac Arrest Study Group demonstrated an 
improvement in survival from witnessed V-fib cardiac arrest from 41% to 55% and an 
improvement in favorable neurologic outcome among survivors from 39% to 55% when TH 
of 32-34°C was maintained for the first 24 hours post cardiac arrest.[12] Bernard 
demonstrated similar neurologic outcome benefits from 12 hours of TH at 32-34°C induced 
on the same patient population in Australia.[13] Recently, a meta-analysis showed that 
therapeutic hypothermia is associated with a risk ratio of 1.68 (95% CI,1.29-2.07) favoring a 
good neurologic outcome when compared with normothermia. The meta-analysis 
concluded the number needed to treat (NNT) to produce one favorable neurological 
recovery was 6.[14] This would translate to improved neurological recovery in > 10,000 
patients per year in the U.S.[14] Also, recent evidence has now shown that the treatment is 
beneficial in cases with non-VF initial rhythm.[15,16,17,18,19]. 
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Current resuscitation guidelines of the International Liaison Committee on Resuscitation 
(ILCOR) recommend induction of TH in post-cardiac arrest patients.[7] In 2005 and then 
upgraded in 2010, the American Heart Association Advanced Cardiac Life Support 
Guidelines recommended that “unconscious adult patients with ROSC after out-of-hospital 
cardiac arrest should be cooled to 32 to 34°C for 12-24 hours….”[20,21]. The guidelines 
identified the need for cooling to occur in the pre-hospital arena, noting that hypothermia 
“should probably be initiated as soon as possible after ROSC….” 
2. Basic science 
A cascade of destructive events and processes begins at the cellular level in the minutes to 
hours following an initial injury. These processes, the result of ischemia and reperfusion, 
may continue for hours to many days after the initial injury.[22] 
When hypothermia was first used in a clinical setting it was presumed that its protective 
effects were due purely to a slowing of cerebral metabolism, leading to reduced glucose and 
oxygen consumption. Cerebral metabolism decreases by 6% to 10% for each 1°C reduction 
in body temperature during cooling.[23,24] This could play a therapeutic effect, but only 
partially. Therapeutic hypothermia can also effectively inhibit apoptosis. [25-27]Hypothermia 
inhibits  the early stages of the programmed cell death process.[26] Thus, inhibiting apoptosis 
is another mechanism by which therapeutic hypothermia could influence the ischemia 
reperfusion injury or secondary injury early on in the disease process. Excitatory processes 
play a major role in the pathophysiology of secondary injury post-cardiac arrest.[23] Evidence 
suggests that hypothermia inhibits these harmful excitatory processes occurring in brain 
cells during ischemia–reperfusion. Ischemic insult to the brain leads to decrease in 
Adenosine triphosphate (ATP) supplies.[23] This culminates into an influx of calcium (Ca) 
into the cell through prolonged glutamate exposure inducing a permanent state of 
hyperexcitability in the neurons (excitotoxicity). All these processes are inhibited  by 
hypothermia very early after injury. Some animal experiments suggest that 
neuroexcitotoxicity can be blocked or reversed only if the treatment is initiated in the very 
early stages of the neuroexcitatory cascade.[28-34] Acute inflammation early after ROSC plays 
a harmful role in postcardiac arrest, including cytokines, macrophages, neutrophils, and 
complement activation, leading to free radical formation. Multiple animal experiments and 
few clinical studies have shown that hypothermia suppresses all these ischemia-induced 
inflammatory reactions, leading to a significant reduction in free radical formation. [35-38] 
Ischemia–reperfusion can also lead to significant disruptions in the blood– brain barrier, 
which can facilitate the subsequent development of brain edema. Mild hypothermia 
significantly reduces blood– brain barrier disruptions, and also decreases vascular 
permeability following ischemia–reperfusion, further decreasing edema formation.[39-41] The 
coagulation cascade is also activated with ischemia-reperfusion injury leading to  
intravascular clot formation resulting in microvascular thrombosis in the brain. [42,43] 
Therapeutic Hypothermia could be beneficial in this instance since platelets number and 
function are decreased with temperatures <35°C, and some inhibition of the coagulation 
cascade develops at temperatures <33°C.[44,45] Vasoconstriction, mediated mainly by 
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thromboxane and endothelin plays a pivotal role in the secondary injury as well. This could 
also be mitigated by hypothermia [46-48]  
It is crucial to note that all of these processes after ischemic-reperfusion injury in the brain 
are temperature dependent; they are all stimulated by fever, and can all be mitigated or 
blocked by hypothermia. Since most of these processes start within minutes to hours after 
the injury, then application of hypothermia earlier might be even more beneficial than 
conventional later application. This has been the premise behind prehospital cooling. 
3. Animal studies 
Animal studies demonstrate a benefit of very early cooling either during CPR or within 15 
minutes of ROSC when cooling is maintained for only a short duration (1 to 2 hours). 
Equivalent neuroprotection was produced in a rat model of cardiac arrest when a 24-hour 
period of cooling was either initiated at the time of ROSC or delayed by 1 hour. In a gerbil 
forebrain ischemia model, sustained neuroprotection was achieved when hypothermia was 
initiated at 1, 6, or 12 hours after reperfusion and maintained for 48 hours; however, 
neuroprotection did decrease when the start of therapy was delayed. Mice receiving intra-
arrest cooling had more favorable hemodynamic and neurological outcomes compared with 
normothermic controls with earlier reperfusion time. In another model, Dogs that received 
hypothermia treatment within 10 minutes of onset of VF had significantly better 
neurological outcomes than those that received it after 20 minutes of VF. [49-53] 
4. Human studies 
Bernard et al., reported the results of a clinical trial of the rapid infusion of large-volume (30 
ml/kg), ice-cold (4°C) lactated ringer’s solution in comatose survivors of OHCA. This study 
found that this approach decreased core temperature by 1.6°C over 25 minutes with no 
adverse events.[54] Polderman, et al., used in addition to surface cooling, 30ml/kg (mean 2.3 
liters) of cold normal saline over 50 minutes that showed similar results.[55] Several small 
randomized trials56-59, and nonrandomized observational and retrospective trials [60-66], 
looked at pre-hospital cooling initiation for patients with OHCA.  
The first randomized controlled trial (RCT) of pre-hospital cooling using large volume ice 
chilled fluid (LVICF) was reported by Kim et al. in 2007. Adult victims of non-traumatic 
cardiac arrest regardless of the initial rhythm were randomized either to field cooling or 
conventional treatment. In EMS before hospital arrival, patients assigned to the treatment 
group were infused up to 2L of 4°C normal saline as soon as possible after resuscitation 
from out-of-hospital cardiac arrest. A total of 125 patients were randomized to receive 
standard care with or without intravenous cooling. Among survivors to hospital admission, 
a significant esophageal temperature decrease of 1.24°C was observed in the treatment 
group compared to a 0.10°C increase in the control group. The authors report no increase in 
the number of adverse events associated with field cooling.[56] Kämäräinen et al conducted a 
similar safety trial in 2009; patients were cooled using LVICF and compared to patients  
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Trial Cooling 
method 
Randomized-
controlled 
Number 
of patients
Temperature 
measurement site 
Complications 
Kim et al 2007 LVICF YES 125 esophageal No difference 
Kämäräinen 
et al 2009 
LVICF YES 37 nasopharyngeal No difference 
Bernard et al 
2010 
LVICF YES 234 Tympanic No difference 
Bernard et al 
2011 
LVICF YES 163 Tympanic No difference 
Castren et al 
2010 
Transnasal 
cooling 
YES 200 Tympanic and core No difference 
Callaway et al 
2002 
Ice Packs NO 22 Nasopharyngeal 
esophageal 
No 
Virkkunen et 
al 2004 
LVICF NO 13 Esophageal 1 hypotension 
Uray et al 
2008 
Cooling 
pads 
NO 15 Esophageal No 
Hammer et al 
2009 
LVICF NO 99 Rectal No difference 
Storm et al 
2008 
Cooling cap NO 45 Tympanic No 
Kämäräinen 
et al 2008 
LVICF NO 17 Nasopharyngeal 5 Re- arrests 
Bruel et al 
2008 
LVICF NO 33 Esophageal 1 Pulmonary 
edema 
Garrett et al 
2011 
ICF 
(2000ml) 
NO 551 Core No difference 
LVICF; large volume ice chilled fluid,  ICF; ice chilled fluid 
Table 1. Clinical Trials on prehospital cooling 
received conventional fluid therapy. Of 44 patients screened, 19 were cooled using LVICF 
and 18 patients received conventional fluid therapy. LVICF resulted in a mean decrease in 
nasopharyngeal temperature of 1.5 °C. At the time of hospital admission, the mean 
nasopharyngeal temperature was markedly lower in the hypothermia group compared to 
the control group; 34.1°C vs. 35.2°C, respectively. Otherwise, there were no significant 
differences between the groups regarding safety parameters.57 Bernard et al, in 2010, 
randomized 234 patients with an initial rhythm of Ventricular fibrillation (VF) to treatment 
group to receive 2L of LVICF by paramedics or to the control group to be cooled after 
hospital admission.[58] Patients allocated to paramedic cooling received a median of 1900 mL 
of ice-cold fluid. This resulted in a mean decrease in core temperature of 0.8°C. However, 
patients in both prehospital TH and control groups had equivalent temperatures at 60 
minutes after hospital arrival (34.7°C). They did not demonstrate any improvement in 
survival to hospital discharge among prehospital-cooled patients when compared with 
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patients receiving TH initiated in the hospital. In a subsequent study, Bernard et al 
randomized 163 patients with an initial rhythm of non-VF to either pre-hospital cooling 
using a rapid infusion of LVICF or cooling after hospital admission.[59] Patients allocated to 
prehospital cooling received a median of 1500 ml of ice-cold fluid. This resulted in a mean 
decrease in core temperature of 1.4°C compared with 0.2°C in hospital cooled patients. 
Although the planned duration of TH in both groups was 24 hours, both groups received a 
mean of 15 hours cooling in the hospital and only 7 patients in each group were cooled for 24 
hours. There was no difference in outcomes at hospital discharge with favorable outcome in 
the pre-hospital cooled patients, compared with in the hospital cooled patients. In another 
randomized, controlled trial in 2010, Castren et al examined the use of transnasal cooling in the 
prehospital setting after ROSC, using an experimental portable delivery device.[60] They 
showed that transnasal cooling was safe and effective during arrest, with a rapid onset of TH 
in the prehospital setting. Although they did not demonstrate a statistically significant 
difference in survival to hospital discharge, there was a trend to increased survival in the 
transnasal cooling group compared with the control group (43.8% vs. 31.0%; p = 0.26). In a 
subset of patients who had CPR initiated within 10 minutes of collapse, there was a statistically 
significant difference in those who survived in the cooled group versus the control group 
(56.5% vs. 29.4%; p = 0.04) and those who were neurologically intact (43.5% vs. 17.6%; p = 0.03). 
Callaway et al in 2002 applied ice to the heads and necks of 9 patients during CPR, and 
compared this to a control group of 13 patients.[61] There was no difference in the rate of 
cooling in this study. Virkkunen et al, in 2004 reported a feasibility study using post ROSC 
infusion of 30 ml/kg LVICF after ROSC. In this cohort of thirteen patients, a significant 
decrease in esophageal temperature was observed, with a mean decrease of 1.9°C compared 
to the temperature prior to the onset of infusion.[62] A transient episode of hypotension was 
observed in one patient, but otherwise the treatment was well tolerated. In 2008, Uray et al 
used self-adhesive cooling pads to induce cooling in the prehospital setting after ROSC in 15 
patients.[63] The rate of cooling was 3.3 °C/h; the target temperature (33 to 34°C) was reached 
in hospital after approximately 91 minutesfrom the time of  ROSC. This study also showed 
that prehospital cooling was feasible and no adverse events were observed. In a 
retrospective review of 22 patients cooled using LVICF in the prehospital setting following 
ROSC compared to 77 conventionally treated patients in 2009, Hammer et al showed 
prehospital cooling to be easible and safe with a mean cooling rate of -1.7 C/h and no 
significant increase in the rate of adverse effects in the cooling group compared to the 
conventional group. [64] Storm et al, in 2008, studied the feasibility of a cranial cooling cap in 
the prehospital setting initiated after ROSC in 20 patients compared to 25 patients serving as 
a non-randomized control group.[65] A 1.1°C decrease in tympanic temperature was 
observed in the treatment group. Also, in 2008, Kämäräinen et al enrolled 17 patients in a 
nonrandomized study where paramedics initiated cooling using LVICF during CPR and 
after ROSC with a target temperature of 33°C.66 The mean infused volume was 1571 ± 517 ml 
and resulted in a mean admission temperature of 33.83 ± 0.77°C (1.34°C decrease compared 
to initial nasopharyngeal temperature). There were no major adverse events. In a similar 
study, Bruel et al enrolled 33 patients out of whom 20 patients had ROSC.67 A mean 
esophageal temperature decrease of 2.1°C was observed. Pulmonary edema occurred in one 
 
Therapeutic Hypothermia in Brain Injury 40 
patient. No other major adverse events occurred. In 2011, Garrett et al performed a 
retrospective analysis of individuals experiencing OHCA  whereby six months into the 
study a prehospital intraarrest TH (IATH) protocol was instituted.68 In this protocol, patients 
received  2000 ml of ICF directly after obtaining intravenous access. 551 patients were 
analysed. Rates of prehospital ROSC were 36.5% versus 26.9% (OR 1.83; 95% CI 1.19–2.81) in 
patients who received IATH versus normothermic resuscitation respectively. While the 
frequency of survival to hospital admission and discharge were increased among those 
receiving IATH, the differences did not reach statistical significance.The secondary analysis 
found a linear association between the amount of cold saline infused and the likelihood of 
prehospital ROSC. They concluded that the infusion of 2000 ml of ICF during the intra-
arrest period may improve rate of ROSC. 
These  studies are either underpowered or due to study design do not allow conclusions 
regarding effects on outcome to be drawn, but the safety and  feasibility of early cooling was 
demonstrated. Another major limitation in most of these studies is that TH is not 
systematically continued in the post resuscitation care occurring in-hospital. Therefore, it is 
not possible to evaluate the benefits of pre-hospital cooling alone, as the effect of TH has 
been shown to necessitate a cooling period of at least 12 to 24 hours. 
5. Methods for induction of prehospital therapeutic hypothermia 
Most of the trials described above (Table 1) used LVICF for induction of TH in the 
prehospital setting. All the studies that used LVICF showed that this method for cooling is 
safe and feasible. However, LVICF may portend some potential problems. In one study on 
cold fluids, it was shown that chilled fluids begin to warm during transit through intravenous 
tubing, but the rate was not rapid enough to be deemed potentially clinically significant.69 In 
addition, in some instances, time to transport from the field to the emergency department may 
be too short for LVICF to have a significant cooling effect. In a study by Spaite et al on 
prehospital cardiac arrest, the time to transport from the field to the hospital was about 7 
minutes.70  In the study by Bernard et al above, 52% of the patients did not receive the goal 
of 2 L chilled saline because the transport time to the hospital was < 20 minutes.58 EMS 
systems with short transport times may not benefit from prehospital TH methods, esp 
chilled fluids, as much as systems that need longer time to get to their respective facilities. 
Another cooling method, used by Castren et al was transnasal cooling, with a machine that 
employs evaporation of an inert liquid sprayed in the posterior nasopharynx.[60] They did 
show that this method of transnasal cooling was safe and effective during arrest, with a 
rapid onset of TH in the prehospital setting. However, it is expensive and not widely 
available at this point. Another method used was cooling pads by Uray et al.[63] They used 
prechilled cooling pads that were stored in an insulated box with a cooling battery. They 
were able to achieve target temperature within about 50 minutes with only mild dermal 
erythema, which resolved soon after removal of the pads. Storm et al used cooling caps that 
proved feasible and with no significant adverse events.[65] Other promising new technologies 
include chilled perfluorocarbons  and saline/ice ‘‘slurries’’, that are still at level of animal 
experimentation.[71,72] 
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6. Complications and problems with prehospital therapeutic 
hypothermia 
The usual side effects pertaining to therapeutic hypothermia in general like arrhythmias, 
electrolyte abnormalities, bleeding, infection and other complications could also happen 
here, however these are discussed in a previous chapter. In this section, I will discuss the 
complications and problems pertinent to the prehospital phase of hypothermia induction. 
Overcooling is a potential problem in the field. It is very important to avoid overcooling 
below the target range because adverse events likely increase when patients are cooled to < 
32°C.[73,74] In a retrospective review, investigators showed that unintentional overcooling 
below target temperature is common, and concluded that improved mechanisms for 
temperature control are required to prevent potentially deleterious complications of more 
profound hypothermia.[75] I also add that effective and accurate methods for prehospital 
temperature monitoring is important, such as tympanic or esophageal temperature 
monitors. Another important complication is shivering, especially in the EMS with some 
limitations on use of antishivering medications, such as neuromascular blockers and some 
sedatives. One important potential problem is the interference of inducing TH in the field 
with the actual CPR and ACLS ongoing on the patient. Some providers believe that basic 
resuscitation care should be prioritized over induction of TH, especially with no proven 
outcome benefit of prehospital TH. A survey of EMS physicians on the implementation rate 
of prehospital cooling in the United States reported that the most common barriers to 
prehospital hypothermia are the lack of ideal equipment and space in EMS vehicles to store 
the equipment that is used to initiate cooling, lack of credentialing for the use of paralytic 
agents, and difficulty in prioritizing for training and patient care.[76] Another problem noted 
from some of the clinical studies addressed above is that after induction of hypothermia in 
the field, some patients were transported to hospitals where TH is not systematically 
continued in the post resuscitation care occurring in-hospital. If a patient is cooled only to be 
rewarmed soon after transport to a facilty, then this may actually be worse than not cooling 
the patient to begin with, as this might reverse and maybe even cause a rebound in all of the 
mechanisms of secondary injury (ischemia-reperfusion) discussed above. Hence, it is very 
important that these patients be transported to a facilty staffed and equipped with the 
ability to continue inhospital therapeutic hypothermia for at least 12-24 hours in addition to 
the other bundles of resuscitative care.[7]  
7. Conclusion 
Animal and laboratory data have suggested that there is significantly decreased 
neurological injury if cooling is initiated as soon as possible after resuscitation. Human 
clinical studies are either underpowered or due to study design do not allow conclusions 
regarding effects on outcome to be drawn, but the safety and  feasibility of early cooling was 
strongly demonstrated. Prehospital cooling comes with its own logistic challenges, such as 
limitation of EMS vehicle space, lack of ideal equipment for induction of hypothermia and 
for temperature monitoring, lack of credentialing for use of paralytic agents by EMS teams 
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that are not staffed by physicians, transport to facilities that are not equipped to continue 
inhospital therapeutic hypothermia and postresuscitation care, the potential for overcooling 
and shivering, and interference with basic resuscitation efforts in the field. Intraarest and 
postarrest bundles of care that include therapeutic hypothermia, as well as training of EMS 
teams, EMS physicians, emergency room staff, cardiologists and cardiac catheterization lab 
staff, and intensive care unit physicians  and staff on these protocols and bundles are crucial 
for the success of these bundles and the implementation of this important therapy, whether 
cooling is initiated in the field or in the hospital setting. Clearly, large prospective 
randomized controlled trials of prehospital therapeutic hypothermia preferably as part of a 
cardiac arrest bundle of care are needed. 
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